Irene Yu Lubenko

683 total citations
20 papers, 538 citations indexed

About

Irene Yu Lubenko is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Irene Yu Lubenko has authored 20 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 12 papers in Molecular Medicine and 11 papers in Infectious Diseases. Recurrent topics in Irene Yu Lubenko's work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Antibiotic Resistance in Bacteria (12 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). Irene Yu Lubenko is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (20 papers), Antibiotic Resistance in Bacteria (12 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). Irene Yu Lubenko collaborates with scholars based in United States, Russia and Italy. Irene Yu Lubenko's co-authors include Stephen H. Zinner, Alexander A. Firsov, Sergey N. Vostrov, Yury A. Portnoy, Karl Drlica, O. V. Kononenko, Р. Г. Василов, Elena N. Strukova, K.L. Greer and Deborah Gilbert and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and International Journal of Antimicrobial Agents.

In The Last Decade

Irene Yu Lubenko

20 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Irene Yu Lubenko United States	10	356	296	225	155	127	20	538
Yury A. Portnoy United States	16	551 1.5×	486 1.6×	248 1.1×	190 1.2×	147 1.2×	44	750
P. Hohl Switzerland	11	260 0.7×	232 0.8×	271 1.2×	231 1.5×	97 0.8×	26	578
Mary S. Barrett United States	13	226 0.6×	163 0.6×	167 0.7×	232 1.5×	84 0.7×	31	473
Laurel S. Almer United States	9	200 0.6×	196 0.7×	207 0.9×	249 1.6×	86 0.7×	10	482
C. J. Henwood United Kingdom	7	115 0.3×	281 0.9×	164 0.7×	110 0.7×	113 0.9×	7	462
Luke Tysall United Kingdom	7	168 0.5×	442 1.5×	191 0.8×	116 0.7×	167 1.3×	11	647
R R Packer United States	11	208 0.6×	189 0.6×	119 0.5×	187 1.2×	76 0.6×	22	418
Nicole Cotroneo United States	11	177 0.5×	290 1.0×	129 0.6×	221 1.4×	56 0.4×	27	544
Renée S. Blosser-Middleton United States	14	164 0.5×	167 0.6×	119 0.5×	277 1.8×	62 0.5×	17	460
S. Vourli Greece	13	146 0.4×	442 1.5×	182 0.8×	127 0.8×	157 1.2×	20	629

Countries citing papers authored by Irene Yu Lubenko

Since Specialization

Citations

This map shows the geographic impact of Irene Yu Lubenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Yu Lubenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Yu Lubenko more than expected).

Fields of papers citing papers by Irene Yu Lubenko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Yu Lubenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Yu Lubenko. The network helps show where Irene Yu Lubenko may publish in the future.

Co-authorship network of co-authors of Irene Yu Lubenko

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Yu Lubenko. A scholar is included among the top collaborators of Irene Yu Lubenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Yu Lubenko. Irene Yu Lubenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lubenko, Irene Yu, Elena N. Strukova, Sergey N. Vostrov, et al.. (2008). Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model. Journal of Antimicrobial Chemotherapy. 62(5). 1065–1069. 9 indexed citations

Zinner, Stephen H., Deborah Gilbert, Irene Yu Lubenko, K.L. Greer, & Alexander A. Firsov. (2008). Selection of linezolid-resistant Enterococcus faecium in an in vitro dynamic model: protective effect of doxycycline. Journal of Antimicrobial Chemotherapy. 61(3). 629–635. 26 indexed citations

Strukova, Elena N., Sergey N. Vostrov, Irene Yu Lubenko, et al.. (2008). Linezolid pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model. International Journal of Antimicrobial Agents. 33(3). 251–254. 8 indexed citations

Firsov, Alexander A., et al.. (2008). Enrichment of Fluoroquinolone-Resistant Staphylococcus aureus : Oscillating Ciprofloxacin Concentrations Simulated at the Upper and Lower Portions of the Mutant Selection Window. Antimicrobial Agents and Chemotherapy. 52(6). 1924–1928. 33 indexed citations

Lubenko, Irene Yu, et al.. (2007). Concentration–response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model. International Journal of Antimicrobial Agents. 29(2). 165–169. 5 indexed citations

Zinner, Stephen H., et al.. (2007). P2062 Bacterial strain-independent anti-staphylococcal effects of telavancin in an in vitro dynamic model that simulates multiple-dose pharmacokinetics in humans. International Journal of Antimicrobial Agents. 29. S595–S595. 1 indexed citations

Firsov, Alexander A., et al.. (2006). Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model. Journal of Antimicrobial Chemotherapy. 58(6). 1185–1192. 75 indexed citations

Vostrov, Sergey N., et al.. (2005). Comparative pharmacodynamics of telithromycin and clarithromycin with and in an in vitro dynamic model: focus on clinically achievable antibiotic concentrations. International Journal of Antimicrobial Agents. 26(3). 197–204. 2 indexed citations

Firsov, Alexander A., et al.. (2005). Comparative pharmacodynamics of the new fluoroquinolone ABT492 and levofloxacin with Streptococcus pneumoniae in an in vitro dynamic model. International Journal of Antimicrobial Agents. 25(5). 409–413. 8 indexed citations

10.

Firsov, Alexander A., Irene Yu Lubenko, Sergey N. Vostrov, Yury A. Portnoy, & Stephen H. Zinner. (2005). Antistaphylococcal Effect Related to the Area under the Curve/MIC Ratio in an In Vitro Dynamic Model: Predicted Breakpoints versus Clinically Achievable Values for Seven Fluoroquinolones. Antimicrobial Agents and Chemotherapy. 49(7). 2642–2647. 19 indexed citations

11.

Firsov, Alexander A., Sergey N. Vostrov, Irene Yu Lubenko, Yury A. Portnoy, & Stephen H. Zinner. (2004). Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination. International Journal of Antimicrobial Agents. 23(5). 451–456. 31 indexed citations

12.

Zinner, Stephen H., et al.. (2004). Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model. International Journal of Antimicrobial Agents. 24(2). 173–177. 11 indexed citations

13.

Firsov, Alexander A., Sergey N. Vostrov, Irene Yu Lubenko, et al.. (2003). In Vitro Pharmacodynamic Evaluation of the Mutant Selection Window Hypothesis Using Four Fluoroquinolones against Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 47(5). 1604–1613. 172 indexed citations

14.

Portnoy, Yury A., Sergey N. Vostrov, Irene Yu Lubenko, Stephen H. Zinner, & Alexander A. Firsov. (2002). Species-independent pharmacodynamics of gemifloxacin and ciprofloxacin with Haemophilus influenzae and Moraxella catarrhalis in an in vitro dynamic model. International Journal of Antimicrobial Agents. 20(3). 201–205. 3 indexed citations

15.

Firsov, Alexander A., Stephen H. Zinner, Irene Yu Lubenko, Yury A. Portnoy, & Sergey N. Vostrov. (2002). Simulated in vitro Quinolone Pharmacodynamics at Clinically Achievable AUC/MIC Ratios: Advantage of <i>I</i><sub>E</sub> over Other Integral Parameters. Chemotherapy. 48(6). 275–279. 7 indexed citations

16.

Lubenko, Irene Yu, Sergey N. Vostrov, Yury A. Portnoy, Stephen H. Zinner, & Alexander A. Firsov. (2002). Bacterial strain-independent AUC/MIC and strain-specific dose–response relationships reflecting comparative fluoroquinolone anti-pseudomonal pharmacodynamics in an in vitro dynamic model. International Journal of Antimicrobial Agents. 20(1). 44–49. 3 indexed citations

17.

Zinner, Stephen H., et al.. (2001). Comparative anti-staphylococcal effects of gemifloxacin and trovafloxacin in an in vitro dynamic model in terms of AUC/MIC and dose relationships. Diagnostic Microbiology and Infectious Disease. 40(4). 167–171. 3 indexed citations

18.

Firsov, Alexander A., Irene Yu Lubenko, Yury A. Portnoy, Stephen H. Zinner, & Sergey N. Vostrov. (2001). Relationships of the Area under the Curve/MIC Ratio to Different Integral Endpoints of the Antimicrobial Effect: Gemifloxacin Pharmacodynamics in an In Vitro Dynamic Model. Antimicrobial Agents and Chemotherapy. 45(3). 927–931. 21 indexed citations

19.

Vostrov, Sergey N., et al.. (2000). Comparative Pharmacodynamics of Gatifloxacin and Ciprofloxacin in an In Vitro Dynamic Model: Prediction of Equiefficient Doses and the Breakpoints of the Area under the Curve/MIC Ratio. Antimicrobial Agents and Chemotherapy. 44(4). 879–884. 19 indexed citations

20.

Firsov, Alexander A., Р. Г. Василов, Sergey N. Vostrov, et al.. (1999). Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacin on staphylococci using an in-vitro dynamic model. Journal of Antimicrobial Chemotherapy. 43(4). 483–490. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact